These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 1560375)
1. Role of the serotonin3 receptor in stress-induced defecation. Miyata K; Kamato T; Nishida A; Ito H; Yuki H; Yamano M; Tsutsumi R; Katsuyama Y; Honda K J Pharmacol Exp Ther; 1992 Apr; 261(1):297-303. PubMed ID: 1560375 [TBL] [Abstract][Full Text] [Related]
2. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo. Kadowaki M; Nagakura Y; Tomoi M; Mori J; Kohsaka M J Pharmacol Exp Ther; 1993 Jul; 266(1):74-80. PubMed ID: 8331576 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of trimebutine and YM114 (KAE-393), a novel 5-HT3 receptor antagonist, on stress-induced defecation. Miyata K; Ito H; Yamano M; Hidaka K; Kamato T; Nishida A; Yuki H Eur J Pharmacol; 1993 Dec; 250(2):303-10. PubMed ID: 8112388 [TBL] [Abstract][Full Text] [Related]
4. 5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome. Kishibayashi N; Miwa Y; Hayashi H; Ishii A; Ichikawa S; Nonaka H; Yokoyama T; Suzuki F J Med Chem; 1993 Oct; 36(22):3286-92. PubMed ID: 8230119 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of phosphodiesterase type 4 decreases stress-induced defecation in rats and mice. Barone FC; Barton ME; White RF; Legos JJ; Kikkawa H; Shimamura M; Kuratani K; Kinoshita M Pharmacology; 2008; 81(1):11-7. PubMed ID: 17726343 [TBL] [Abstract][Full Text] [Related]
6. Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized rats. Miyata K; Kamato T; Yamano M; Nishida A; Ito H; Katsuyama Y; Yuki H; Tsutsumi R; Ohta M; Takeda M J Pharmacol Exp Ther; 1991 Nov; 259(2):815-9. PubMed ID: 1941629 [TBL] [Abstract][Full Text] [Related]
7. Melatonin attenuates stress-induced defecation: lesson from a rat model of stress-induced gut dysfunction. Song GH; Gwee KA; Moochhala SM; Ho KY Neurogastroenterol Motil; 2005 Oct; 17(5):744-50. PubMed ID: 16185314 [TBL] [Abstract][Full Text] [Related]
8. Effect of GK-128 [2-[(2-methylimidazol-1-yl)methyl]-benzo[f]thiochromen-1-one monohydrochloride hemihydrate], a selective 5-hydroxytryptamine3 receptor antagonist, on colonic function in rats. Ito C; Isobe Y; Kawamura R; Kiuchi Y; Tsuchida K; Higuchi S J Pharmacol Exp Ther; 1997 Jan; 280(1):67-72. PubMed ID: 8996183 [TBL] [Abstract][Full Text] [Related]
9. Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats. Funatsu T; Takeuchi A; Hirata T; Keto Y; Akuzawa S; Sasamata M Eur J Pharmacol; 2007 Nov; 573(1-3):190-5. PubMed ID: 17658508 [TBL] [Abstract][Full Text] [Related]
10. Effect of YNS-15P, a new alpha-2 adrenoceptor antagonist, on stress-stimulated colonic propulsion in rats. Yamamoto O; Niida H; Tajima K; Shirouchi Y; Kyotani Y; Ueda F; Kise M; Kimura K J Pharmacol Exp Ther; 1998 Nov; 287(2):691-6. PubMed ID: 9808698 [TBL] [Abstract][Full Text] [Related]
11. Wood creosote prevents CRF-induced motility via 5-HT3 receptors in proximal and 5-HT4 receptors in distal colon in rats. Ataka K; Kuge T; Fujino K; Takahashi T; Fujimiya M Auton Neurosci; 2007 May; 133(2):136-45. PubMed ID: 17182287 [TBL] [Abstract][Full Text] [Related]
12. EFFECT OF 5-HT3 ANTAGONIST ONDANSETRON ON WRAP-RESTRAINT AND CONDITIONED EMOTIONAL STRESS INDUCED DEFECATION. Karan RS; Saha L; Handu SS; Bhargava VK Indian J Physiol Pharmacol; 1999 Jan; 43(1):129-32. PubMed ID: 27093752 [TBL] [Abstract][Full Text] [Related]
13. Involvement of the 5-HT3 receptor in CRH-induce defecation in rats. Miyata K; Ito H; Fukudo S Am J Physiol; 1998 May; 274(5):G827-31. PubMed ID: 9612262 [TBL] [Abstract][Full Text] [Related]
14. Luminal hypotonicity increases duodenal mucosal permeability by a mechanism involving 5-hydroxytryptamine. Nylander O; Pihl L Acta Physiol (Oxf); 2006 Jan; 186(1):45-58. PubMed ID: 16497179 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of ramosetron, a novel therapeutic agent for IBS. Hirata T; Funatsu T; Keto Y; Nakata M; Sasamata M Inflammopharmacology; 2007 Feb; 15(1):5-9. PubMed ID: 17323187 [TBL] [Abstract][Full Text] [Related]
16. Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats. Yamano M; Kamato T; Nishida A; Ito H; Yuki H; Tsutsumi R; Honda K; Miyata K Jpn J Pharmacol; 1994 Jul; 65(3):241-8. PubMed ID: 7799524 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist. Nagakura Y; Kadowaki M; Tokoro K; Tomoi M; Mori J; Kohsaka M J Pharmacol Exp Ther; 1993 May; 265(2):752-8. PubMed ID: 8496821 [TBL] [Abstract][Full Text] [Related]
18. Chronic stress-induced alterations in mouse colonic 5-HT and defecation responses are strain dependent. Julio-Pieper M; O'Mahony CM; Clarke G; Bravo JA; Dinan TG; Cryan JF Stress; 2012 Mar; 15(2):218-26. PubMed ID: 21875301 [TBL] [Abstract][Full Text] [Related]
19. Participation of a cholinergic mechanism in 5-hydroxytryptamine (5-HT)3 and 5-HT4 receptor-mediated stimulation of gastric emptying in rats. Yamano M; Kamato T; Miyata K Arzneimittelforschung; 1997 Nov; 47(11):1242-6. PubMed ID: 9428982 [TBL] [Abstract][Full Text] [Related]
20. Effects of YM905, a novel muscarinic M3-receptor antagonist, on experimental models of bowel dysfunction in vivo. Kobayashi S; Ikeda K; Suzuki M; Yamada T; Miyata K Jpn J Pharmacol; 2001 Jul; 86(3):281-8. PubMed ID: 11488427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]